Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 26, 2006Antimicrobial Agents and ChemotherapyOpen Access

Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci

View Full Paper
Ask AI
Bookmark
Share

Authors

RJRonald N. JonesNorthwestern UniversityTFThomas R. FritscheMarshfield ClinicHSHélio S. SaderJMI Laboratories

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jones et al. (2006) studied this question.

synapsesocial.com/papers/6a83ccff20cfb2932ffe220fhttps://doi.org/10.1128/aac.01432-05
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quality Control Guidelines for Susceptibility Testing of Retapamulin (SB-275833) by Reference and Standardized Methods2005 · 12 citations
  2. 2National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  3. 3A Comparative Study with Two Administration Schedules of Leucovorin and 5-Fluorouracil in Advanced Colorectal Cancer1995 · 6 citations